TrialArthritis research & therapy2017

Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout.

Leonard H Calabrese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.